Physicochemical Properties
| Molecular Formula | C20H21F3N2O2 |
| Molecular Weight | 378.39 |
| Exact Mass | 378.156 |
| CAS # | 1110781-88-8 |
| PubChem CID | 25175634 |
| Appearance | White to off-white solid powder |
| LogP | 5.094 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Heavy Atom Count | 27 |
| Complexity | 494 |
| Defined Atom Stereocenter Count | 0 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Hippocampal pyramidal neurons' excitability is inhibited by Ro 5212773 (EPPTB). Additionally, EPPTB lowers seizure activity and epileptiform events (SLE) [1]. Inward rectifier K+ current activation mediated by TAAR1 is blocked by Ro 5212773 [2]. 1.5 μM β-phenylethylamine (IC50=27.5 nM) potently inhibits the production of cAMP induced by mouse TAAR1 activation. This is achieved by Ro 5212773. In the absence of TAAR1 agonist, Ro 5212773 dose-dependently lowers cAMP levels in HEK293 cells (IC50= 19 nM). Compared to rat (IC50= 4539 nM) and human (IC50= 7487 nM) TAAR1, EPPTB significantly more effectively inhibits the production of cAMP in mice [2]. |
| References |
[1]. The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system. Proc Natl Acad Sci U S A. 2009;106(47):20081-20086. |
Solubility Data
| Solubility (In Vitro) | DMSO: 100 mg/mL (264.28 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (6.61 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.6428 mL | 13.2139 mL | 26.4278 mL | |
| 5 mM | 0.5286 mL | 2.6428 mL | 5.2856 mL | |
| 10 mM | 0.2643 mL | 1.3214 mL | 2.6428 mL |